(Q43826641)

27 November 2017

title

Beneficial effects of the Ca(2+) sensitizer levosimendan in human myocardium (English)

1 reference

27 November 2017

Klara Brixius

1

1 reference

27 November 2017

Sebastian Reicke

series ordinal

2

1 reference

27 November 2017

Robert H G Schwinger

series ordinal

3

1 reference

27 November 2017

publication date

1 January 2002

1 reference

American Journal of Physiology Heart and Circulatory Physiology

27 November 2017

published in

1 reference

27 November 2017

volume

282

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

H131-7

1 reference

The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2002.282.1.H131

Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2002.282.1.H131

Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2002.282.1.H131

Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2002.282.1.H131

10.1152/AJPHEART.2002.282.1.H131

21 January 2018

Identifiers

DOI

0 references

1 reference